LifeStance Health reports new anxiety medications are expected for 2026, featuring innovative treatments in clinical trials ...

New findings suggest that a protein known as Reelin could play a role in treating both “leaky gut” and severe depression.

Biotech stock GH Research catapulted Monday after the FDA gave it the go-ahead to resume testing its depression drug.

Swedish neurotech startup Flow Neuroscience has secured FDA approval for the first brain stimulation device for home use in ...

The Food and Drug Administration lifted the clinical hold on GH Research's investigational new drug application for its GH001 drug for treatment-resistant depression. The company said the lift allows ...

In a major shift for how mental health conditions might be treated, the US Food and Drug Administration (FDA) has approved ...

Radial reports that teen depression is prevalent yet under-treated. Effective options include therapy, antidepressants, and ...

Researchers compared a traditional Chinese medicine, Yueju Pill, with a standard antidepressant and found both reduced ...

The University of Iowa Health Care has introduced a new treatment for depression through its outpatient clinic — Stanford Accelerated Intelligent Neuromodulation Therapy, or SAINT therapy. The therapy ...

“It provides an important foothold for identifying new diagnostic markers and therapeutic targets beyond neurotransmitters.” While the findings were only demonstrated in the brains of male mice – and, ...

Many clinical trials to test the use of psychedelic medicines for conditions such as depression have been underway since 2022 ...

A new brief report published in JAMA Psychiatry finds that the instructions for the Patient Health Questionnaire (PHQ), a ...